About me
Rob DiCicco is the Vice President, Portfolio Management at TransCelerate Biopharma, Inc. where for the last 3 years he has headed up a suite of programs that include Pragmatic Trials along with several digital and data driven transformational projects. He was the Chief Health Officer at IBM Watson Health from 2018-2021. Prior to joining IBM, Rob had a long career with GlaxoSmithKline where he served in a variety of leadership positions. Rob received his Doctor of Pharmacy Degree from the Philadelphia College of Pharmacy and Sciences. His areas of expertise and interest include clinical trial design, clinical operations, protocol quality, and ethics in research.
